Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie R Harrison

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Expert Review of Clinical Immunology|August 19, 2021
Ixekizumab: an IL-17A inhibitor for the treatment of axial SpondylarthritisStephanie R Harrison, Helena Marzo-Ortega
Therapeutic Advances in Musculoskeletal Disease|July 29, 2024
Early psoriatic arthritis: when is the right time to start advanced therapy?Or Hen, Stephanie R Harrison, Gabriele De Marco, et al.
Calcified Tissue International|July 10, 2019
Vitamin D, Autoimmune Disease and Rheumatoid ArthritisStephanie R Harrison, Danyang Li, Louisa E Jeffery, et al.
Seminars in Immunopathology|May 22, 2015
Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyondAmma F Agyemang, Stephanie R Harrison, Richard M Siegel, et al.
Rheumatology (Oxford, England)|January 4, 2021
Interferon-related gene expression in response to TNF inhibitor treatment in ankylosing spondylitis patients: a pilot studyStephanie R Harrison, Agata N Burska, Paul Emery, et al.
Polish Archives of Internal Medicine|January 2, 2024
Recent advances in the management of psoriatic arthritis: practical considerationsStephanie R Harrison, B Naw Ra Aung Din, Helena Marzo-Ortega, et al.
BMC Rheumatology|July 31, 2020
Vitamin D and early rheumatoid arthritisStephanie R Harrison, Gurpreet Jutley, Danyang Li, et al.
Frontiers in Immunology|February 23, 2018
Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three <i>TNFRSF1A</i> Mutations Results in Hyperresponsiveness to LipopolysaccharideStephanie R Harrison, Thomas Scambler, Lylia Oubussad, et al.
JCI Insight|October 5, 2016
Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiologyStephanie R Harrison, Dennis McGonagle, Sharmin Nizam, et al.
Rheumatology (Oxford, England)|July 17, 2021
Subjective loss of clinical response to TNFi in axSpA relates to recurrence of MRI bone marrow oedema particularly with long-acting agentsStephanie R Harrison, Rebecca Ansell, Hannah R Mathieson, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Expert Review of Clinical Immunology|August 19, 2021
Ixekizumab: an IL-17A inhibitor for the treatment of axial SpondylarthritisStephanie R Harrison, Helena Marzo-Ortega
Therapeutic Advances in Musculoskeletal Disease|July 29, 2024
Early psoriatic arthritis: when is the right time to start advanced therapy?Or Hen, Stephanie R Harrison, Gabriele De Marco, et al.
Calcified Tissue International|July 10, 2019
Vitamin D, Autoimmune Disease and Rheumatoid ArthritisStephanie R Harrison, Danyang Li, Louisa E Jeffery, et al.
Seminars in Immunopathology|May 22, 2015
Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyondAmma F Agyemang, Stephanie R Harrison, Richard M Siegel, et al.
Rheumatology (Oxford, England)|January 4, 2021
Interferon-related gene expression in response to TNF inhibitor treatment in ankylosing spondylitis patients: a pilot studyStephanie R Harrison, Agata N Burska, Paul Emery, et al.
Polish Archives of Internal Medicine|January 2, 2024
Recent advances in the management of psoriatic arthritis: practical considerationsStephanie R Harrison, B Naw Ra Aung Din, Helena Marzo-Ortega, et al.
BMC Rheumatology|July 31, 2020
Vitamin D and early rheumatoid arthritisStephanie R Harrison, Gurpreet Jutley, Danyang Li, et al.
Frontiers in Immunology|February 23, 2018
Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three <i>TNFRSF1A</i> Mutations Results in Hyperresponsiveness to LipopolysaccharideStephanie R Harrison, Thomas Scambler, Lylia Oubussad, et al.
JCI Insight|October 5, 2016
Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiologyStephanie R Harrison, Dennis McGonagle, Sharmin Nizam, et al.
Rheumatology (Oxford, England)|July 17, 2021
Subjective loss of clinical response to TNFi in axSpA relates to recurrence of MRI bone marrow oedema particularly with long-acting agentsStephanie R Harrison, Rebecca Ansell, Hannah R Mathieson, et al.
Pageof 3